Implant Survival and Autologous Breast Augmentation in Rupture Management.
Long-term silicone breast implant survival was 83% at 20 years.
Implant Survival and Autologous Breast Augmentation in Rupture Management.
Silicone breast implants remain a mainstay of aesthetic surgery; however, long-term rupture remains a significant complication.
The purpose of this study was to evaluate long-term implant survival and the outcomes of hybrid autologous augmentation using pedicled transverse rectus abdominis myocutaneous flap and fat grafting following explantation for rupture.
A retrospective review was conducted on 150 female patients with 179 ruptured implants (June 2022-September 2024).
MRI demonstrated linguine (25.1%), teardrop (15.6%), and combined rupture signs.
The mean BREAST-Q satisfaction score was 62.7, positively correlating with volume retention ( r = 0.317, P = .043).
Hybrid autologous breast augmentation using a transverse rectus abdominis myocutaneous flap and fat grafting is a reliable and aesthetically satisfying alternative to reimplantation.
MRI facilitates accurate rupture diagnosis and postoperative volumetric monitoring. This technique also yields abdominal contouring benefits and reduced long-term costs, making it an attractive option for selected patients.